Skip to main content
Premium Trial:

Request an Annual Quote

Japan s MediBic Alliance Takes 10 Percent Stake in Strand Genomics

NEW YORK, Sept. 16 (GenomeWeb News) -- MediBic Alliance, the investment arm of Japanese company MediBic, has acquired a 10 percent stake in Strand Genomics of Bangalore, according to news reports in India.

Financial details of the deal, which was reported on, an India-based financial web portal, were not disclosed.

MediBic, a life sciences consultancy, and Strand last month announced a partnership to jointly develop and market informatics products to pharmaceutical customers in Japan and provide consulting and customization services in genomics, proteomics, clinical studies, predictive ADME/Toxicology, and other research and development areas.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.